vs
Side-by-side financial comparison of Kartoon Studios, Inc. (TOON) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.
Xilio Therapeutics, Inc. is the larger business by last-quarter revenue ($13.7M vs $9.7M, roughly 1.4× Kartoon Studios, Inc.). Xilio Therapeutics, Inc. runs the higher net margin — 75.7% vs -54.4%, a 130.1% gap on every dollar of revenue. Kartoon Studios, Inc. produced more free cash flow last quarter ($346.0K vs $-2.1M).
Kartoon Studios, Inc. is an entertainment company headed by Andy Heyward. The company was formed in 2010 as Genius Brands International (GBI) from the merger of Genius Brands International and A Squared Entertainment.
Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.
TOON vs XLO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.7M | $13.7M |
| Net Profit | $-5.3M | $10.4M |
| Gross Margin | — | — |
| Operating Margin | -38.4% | -86.5% |
| Net Margin | -54.4% | 75.7% |
| Revenue YoY | 2.9% | — |
| Net Profit YoY | 8.5% | 179.1% |
| EPS (diluted) | $-0.08 | $-3.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.7M | $13.7M | ||
| Q3 25 | $9.9M | $19.1M | ||
| Q2 25 | $10.3M | $8.1M | ||
| Q1 25 | $9.5M | $2.9M | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $8.7M | — | ||
| Q2 24 | $8.4M | — | ||
| Q1 24 | $6.1M | — |
| Q4 25 | $-5.3M | $10.4M | ||
| Q3 25 | $-6.6M | $-16.3M | ||
| Q2 25 | $-6.2M | $-15.8M | ||
| Q1 25 | $-6.5M | $-13.3M | ||
| Q4 24 | $-5.8M | — | ||
| Q3 24 | $-2.1M | — | ||
| Q2 24 | $-5.9M | — | ||
| Q1 24 | $-7.0M | — |
| Q4 25 | -38.4% | -86.5% | ||
| Q3 25 | -29.3% | -10.1% | ||
| Q2 25 | -31.3% | -177.7% | ||
| Q1 25 | -32.4% | -472.7% | ||
| Q4 24 | -37.1% | — | ||
| Q3 24 | -29.2% | — | ||
| Q2 24 | -55.6% | — | ||
| Q1 24 | -103.6% | — |
| Q4 25 | -54.4% | 75.7% | ||
| Q3 25 | -66.5% | -85.4% | ||
| Q2 25 | -60.0% | -196.0% | ||
| Q1 25 | -68.7% | -452.7% | ||
| Q4 24 | -61.2% | — | ||
| Q3 24 | -23.6% | — | ||
| Q2 24 | -70.1% | — | ||
| Q1 24 | -115.9% | — |
| Q4 25 | $-0.08 | $-3.74 | ||
| Q3 25 | $-0.14 | $-0.11 | ||
| Q2 25 | $-0.13 | $-0.16 | ||
| Q1 25 | $-0.14 | $-0.18 | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.05 | — | ||
| Q2 24 | $-0.15 | — | ||
| Q1 24 | $-0.20 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $26.2M | $35.3M |
| Total Assets | $70.9M | $154.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $103.8M | ||
| Q2 25 | — | $121.6M | ||
| Q1 25 | — | $89.1M | ||
| Q4 24 | $100.0K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $26.2M | $35.3M | ||
| Q3 25 | $22.6M | $-8.1M | ||
| Q2 25 | $28.4M | $7.1M | ||
| Q1 25 | $28.6M | $10.7M | ||
| Q4 24 | $35.0M | — | ||
| Q3 24 | $41.2M | — | ||
| Q2 24 | $42.7M | — | ||
| Q1 24 | $44.8M | — |
| Q4 25 | $70.9M | $154.7M | ||
| Q3 25 | $66.7M | $133.7M | ||
| Q2 25 | $70.0M | $133.8M | ||
| Q1 25 | $71.7M | $103.7M | ||
| Q4 24 | $85.5M | — | ||
| Q3 24 | $87.3M | — | ||
| Q2 24 | $89.0M | — | ||
| Q1 24 | $93.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $381.0K | $-2.0M |
| Free Cash FlowOCF − Capex | $346.0K | $-2.1M |
| FCF MarginFCF / Revenue | 3.6% | -15.3% |
| Capex IntensityCapex / Revenue | 0.4% | 0.7% |
| Cash ConversionOCF / Net Profit | — | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | $-11.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $381.0K | $-2.0M | ||
| Q3 25 | $-5.5M | $-17.5M | ||
| Q2 25 | $-4.5M | $-14.5M | ||
| Q1 25 | $-1.8M | $29.0M | ||
| Q4 24 | $-2.4M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $-6.5M | — | ||
| Q1 24 | $3.8M | — |
| Q4 25 | $346.0K | $-2.1M | ||
| Q3 25 | $-5.5M | — | ||
| Q2 25 | $-4.5M | $-14.9M | ||
| Q1 25 | $-1.8M | $29.0M | ||
| Q4 24 | $-2.4M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $3.8M | — |
| Q4 25 | 3.6% | -15.3% | ||
| Q3 25 | -56.0% | — | ||
| Q2 25 | -44.1% | -184.0% | ||
| Q1 25 | -19.4% | 988.3% | ||
| Q4 24 | -25.6% | — | ||
| Q3 24 | 17.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 62.7% | — |
| Q4 25 | 0.4% | 0.7% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.6% | 5.0% | ||
| Q1 25 | 0.2% | 0.8% | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TOON
| Other | $4.6M | 48% |
| CA | $2.8M | 29% |
| Content Distribution | $2.2M | 23% |
XLO
Segment breakdown not available.
